AlphAIAlphAI — Financial news for AI agents
tradingview.comOCT 91 min read

Fortrea Holdings Inc. Stock 12‑Month Price Target Raised to $21.73, Implies 7% Upside

Fortrea Holdings Inc.'s average stock price target increased from $21.5 to $21.73, with a range of $15.5 to $26, according to 11 analysts. This implies a 7% upside from the Oct. 8 closing price. The consensus rating is 'Buy' among 14 analysts, with 6 Buys, 6 Holds, and 2 Sells.

Original reporting
tradingview.com
Published Oct 9, 2026, 4:20 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 9, 2026, 4:25 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
Fortrea Holdings Inc. Stock 12‑Month Price Target Raised to $21.73, Implies 7% Upside — source image
Source · tradingview.com
Decision brief

The 30-second read

Low
01

Why it matters

Analyst consensus upgrade to Buy and higher price target could attract short‑term interest.

02

Market read

Analyst target raise offers modest upside potential but limited broader market impact.

03

What to watch

Potential downside if upcoming earnings miss expectations.

Relevance 5/10Novelty 5/10Timing: today

Background

Fortrea Holdings is a small‑cap healthcare services company; price target changes are closely watched by niche investors.

Market effects

Sector

Minor positive signal for the healthcare services sector.

Regional

Limited to U.S. small‑cap investors.

Global

Low

Counterpoint

What could challenge this read

Target raise may be premature without concrete earnings beat.

Key entities

  • company
    Fortrea Holdings Inc.

    U.S. listed healthcare services firm (NASDAQ:FTR).

Read at source← All news

Related articles

OCT 15
$FTREHigh

Why is Fortrea stock gaining today?

Fortrea Holdings Inc. (FTRE) stock rose 3.8% in pre-market trading after Deutsche Bank upgraded it to Buy with a $25 price target, citing confidence in its recovery. Zacks Research downgraded it to Strong Sell. The company's Q3 2026 earnings release is scheduled for October 29. The broader market is down due to inflation concerns, but FTRE's advance is notable.

investing.com1 min
OCT 6
$FTREHigh

Fortrea (FTRE) Stock Trades Up, Here Is Why

Fortrea Holdings (FTRE) stock rose 3.3% premarket after Barclays upgraded it to Overweight with a $38 price target, citing resilient bookings and margin recovery potential. The company reported Q3 revenue of $701.3M, beating estimates, and raised full-year revenue guidance to $2.73B midpoint. FTRE shares are up 34.1% YTD, reaching a 52-week high.

financialcontent.com2 min
OCT 6
High

Why is Fortrea stock surging today?

Fortrea Holdings Inc. stock rose 8.7% after Barclays upgraded it to Overweight and raised its price target to $23. The stock hit a 52-week high of $23.51 before closing at $22.95. Barclays cited optimism about the life sciences sector and Fortrea's near-term outlook. UBS also upgraded Fortrea to Hold, and the company has scheduled its Q3 2026 earnings release for October 29. The broader market was positive, with the S&P 500, Dow Jones, and Nasdaq each gaining 0.6%.

investing.com2 min